Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 639-657 , August 2008

Acromegaly, growth hormone and cancer risk

  • Andrew G. Renehan, PhD, FRCS (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Surgery, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. Tel.: +44 161 446 3157; Fax: +44 161 446 3365.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00097-3

doi: 10.1016/j.beem.2008.08.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 639-657 , August 2008

Article Tools

* Image Usage & Resolution